The Facial Erythema Treatment Market is experiencing steady growth, driven by rising prevalence of dermatological conditions and increasing awareness of advanced treatment options. Valued at US$ 198 million in 2024, the market is projected to expand at a CAGR of 5.6% from 2025 to 2032. The growing demand for effective and targeted therapies, combined with technological advancements in...